Dr Manzanilla Pediatric by Key Therapeutics Dr Manzanilla Pediatric

Dr Manzanilla Pediatric by

Drug Labeling and Warnings

Dr Manzanilla Pediatric by is a Otc medication manufactured, distributed, or labeled by Key Therapeutics. Drug facts, warnings, and ingredients follow.

Drug Details [pdf]

DR MANZANILLA PEDIATRIC- triprolidine hydrochloride syrup 
Key Therapeutics

Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

----------

Dr Manzanilla Pediatric

Dr. Manzanilla Pediatric Syrup

Key Therapeutics, LLC

Disclaimer: Most OTC drugs are not reviewed and approved by FDA; however, they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

Dr. Manzanilla Pediatric Syrup

Drug Facts

Active ingredients (in each 5 mL teaspoonful)

Purpose

Triprolidine HCI……….2.5 mg…………Antihistamine

Inactive Ingredients:

Sodium Benzoate, Purified Water, Hydroxypropyl Cellulose, Sorbitol, Bubblegum

Flavor.

Uses

temporarily relieves these symptoms due to hay fever (allergic rhinitis) or other upper respiratory allergies:

  • cough due to minor throat or bronchial irritation
  • runny nose
  • sneezing
  • itching of the nose or throat
  • itchy, watery eyes
  • nasal congestion (reduces swelling of nasal passages)

Warnings:

Do not exceed recommended dosage.

Ask a doctor before use if you have

  • a breathing problem such as emphysema or chronic bronchitis
  • heart disease, high blood pressure, thyroid disease, diabetes, glaucoma
  • a persistent or chronic cough such occurs with smoking, asthma
  • a cough that occurs with too much phlegm (mucus)
  • trouble urinating due to an enlarged prostate gland.

Ask a doctor before use if you are taking sedatives or tranquilizers.

When using this product

  • excitability may occur, especially in children may cause drowsiness
  • alcohol, sedatives and tranquilizers may increase the drowsiness effect avoid alcoholic beverages
  • use caution when driving a motor vehicle or operating machinery

Stop use and ask a doctor if:

  • nervousness, dizziness or sleeplessness occur 
  • cough or nasal congestion persists for more than 1 week, tends to recur or is accompanied by a fever, rash or persistent headache. These could be signs of a more serious condition.
  • if new symptoms occur

These can be signs of a serious condition.

If pregnant or breastfeeding, ask a health professional before use.

KEEP THIS PRODUCT OUT OF REACH OF CHILDREN.

In case of overdose, get medical help or contact a Poison Control Center right away.

Do not exceed recommended dosage.

Directions:

AGEDOSE
Adults and Children 12 years of age and older:1 teaspoonful (5 mL) every 4 hours, not to exceed 4 teaspoonfuls (20 mL) in 24 hours or as directed by a doctor.
Children 6 to under 12 years of age:½ teaspoonful (2.5 mL) every 4 hours, not to exceed 2 teaspoonfuls (10 mL) in 24 hours or as directed by a doctor.
Children under 6 years of age:Consult a doctor

Other Information

Store at 15°-30 ° C (59 °-86 ° F).

Tamper evident by foil seal under cap. Do not use if foil seal is missing or broken. Dispense in a tight, light-resistant container with a child-resistant cap.

Questions?

Comments?

Call 1-888-981-8337

Manufactured for:

Key Therapeutics, LLC

Flowood, MS 39232

PRINCIPAL DISPLAY PANEL

NDC: 70868-702-08
Dr. Manzanilla
Pediatric

Bubble Gum Flavor

8
fl oz (237 mL)

PRINCIPAL DISPLAY PANEL
NDC: <a href=/NDC/70868-702-08>70868-702-08</a>
Dr. Manzanilla 
Pediatric 
Bubble Gum Flavor
8 fl oz (237 mL)

DR MANZANILLA PEDIATRIC 
triprolidine hydrochloride syrup
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC: 70868-702
Route of AdministrationORAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
TRIPROLIDINE HYDROCHLORIDE (UNII: YAN7R5L890) (TRIPROLIDINE - UNII:2L8T9S52QM) TRIPROLIDINE HYDROCHLORIDE2.5 mg  in 5 mL
Inactive Ingredients
Ingredient NameStrength
SODIUM BENZOATE (UNII: OJ245FE5EU)  
WATER (UNII: 059QF0KO0R)  
HYDROXYPROPYL CELLULOSE, UNSPECIFIED (UNII: 9XZ8H6N6OH)  
SORBITOL (UNII: 506T60A25R)  
Product Characteristics
Color    Score    
ShapeSize
FlavorBUBBLE GUMImprint Code
Contains    
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC: 70868-702-08237 mL in 1 BOTTLE; Type 0: Not a Combination Product08/11/201903/31/2020
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC MONOGRAPH FINALpart34108/11/201903/31/2020
Labeler - Key Therapeutics (080318791)

Revised: 4/2020
 
Key Therapeutics